Evidence map›Paper›PMID 37463764›Full record

ArticleBMJ evidence-based medicine2024

Reducing the residue of retractions in evidence synthesis: ways to minimise inappropriate citation and use of retracted data.

Caitlin Bakker, Stephanie Boughton, Clovis Mariano Faggion, Daniele Fanelli, Kathryn Kaiser, Jodi Schneider

Abstract read
In one paragraph

Article in BMJ evidence-based medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Cost of Retracted Articles to the NIH: a Living Analysis.medRxiv : the preprint server for health sciences · 2026
    Article
  8. Article
  9. Article
  10. Nine changes needed to deliver a radical transformation in biodiversity measurement.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Trust me: You can't trust everything that you read.Proceedings (Baylor University. Medical Center) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Caitlin BakkerDr. John Archer Library, University of Regina, Regina, Saskatchewan, Canada.ORCID 0000-0003-4154-8382
Stephanie BoughtonResearch Integrity team, Editorial & Methods Department, Cochrane, London, UK.
Clovis Mariano FaggionDepartment of Periodontology and Operative Dentistry, Faculty of Dentistry, University Hospital Münster, Münster, Germany.ORCID 0000-0001-8323-909X
Daniele FanelliLondon School of Economics and Political Science, Dept. of Methodology, London, UK.ORCID 0000-0003-1780-1958
Kathryn KaiserThe University of Alabama at Birmingham, Birmingham, Alabama, USA.ORCID 0000-0002-6258-4369
Jodi SchneiderSchool of Information Sciences, University of Illinois Urbana-Champaign, Champaign, Illinois, USA jschneider@pobox.com jodi@illinois.edu.ORCID 0000-0002-5098-5667

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The incorporation of publications that have been retracted is a risk in reliable evidence synthesis. Retraction is an important mechanism for correcting the literature and protecting its integrity. Within the medical literature, the continued citation of retracted publications occurs for a variety of reasons. Recent evidence suggests that systematic reviews and meta-analyses often unwittingly cite retracted publications which, at least in some cases, may significantly impact quantitative effect estimates in meta-analyses. There is strong evidence that authors of systematic reviews and meta-analyses may be unaware of the retracted status of publications and treat them as if they are not retracted. These problems are difficult to address for several reasons: identifying retracted publications is important but logistically challenging; publications may be retracted while a review is in preparation or in press and problems with a publication may also be discovered after the evidence synthesis is published. We propose a set of concrete actions that stakeholders (eg, scientists, peer-reviewers, journal editors) might take in the near-term, and that research funders, citation management systems, and databases and search engines might take in the longer term to limit the impact of retracted primary studies on evidence syntheses.

Indexed as

Scientific MisconductDatabases, BibliographicHumansMeta-Analysis as TopicSystematic Reviews as TopicEvidence-Based PracticeInformation Storage and RetrievalPublishingRetraction of Publication as TopicSystematic Reviews as Topic

Identifiers

PMID37463764
PMCPMC10982619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.